Experimental validation in a thioacetamide-induced zebrafish NAFLD model showed that Tet significantly reduced hepatic lipid accumulation and decreased serum TG, TC, ALT, and AST levels. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.